Your browser version may not work well with NCBI's Web applications. More information here...
1: Tumori. 2008 Mar-Apr;94(2):264-70.Links

Nanoparticles for imaging and tumor gene delivery.

Richard C, de Chermont Qle M, Scherman D.

Unité de Pharmacologie Chimique et Génétique, CNRS, UMR 8151, Paris, France.

Molecular imaging of receptors expressed on the surface of tumor cells is becoming a major field of investigation in clinical oncology, especially for the detection of cancer at its earliest stages. Nowadays, MRI, microcomputed tomography (microCT), ultrasound, positron emission tomography (PET), optical coherence tomography (OCT), and other major imaging systems are available to scientists and clinicians. Each technique has advantages and limitations, thus making them complementary. We report herein our investigations on the synthesis and use of new probes for small animal imaging as well as on the preparation and use of targeting complexes to deliver specific gene in tumors cells.

PMID: 18564615 [PubMed - indexed for MEDLINE]